|
Secondary prevention
Citations 11-20 of 568 total displayed.
|
Past content
(since Feb 1999):
|
- Epidemiology and Prevention
Bleeding Increases the Risk of Ischemic Events in Patients With Peripheral Arterial Disease
- Eline S. van Hattum, Ale Algra, James A. Lawson, Bert C. Eikelboom, Frans L. Moll, and Marco J.D. Tangelder
Circulation 2009;120:1569-1576; published online before print as doi:10.1161/CIRCULATIONAHA.109.858365
[Abstract]
[Full text]
- Articles
Iloprost Prevents Contrast-Induced Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention
- Konstantinos Spargias, Elias Adreanides, Eftihia Demerouti, Angeliki Gkouziouta, Athanassios Manginas, Gregory Pavlides, Vassilis Voudris, and Dennis V. Cokkinos
Circulation published October 19, 2009, doi:10.1161/CIRCULATIONAHA.109.863159
[Abstract]
- Epidemiology and Prevention
Cardiovascular Benefit of Magnitude of Low-Density Lipoprotein Cholesterol Reduction: A Comparison of Subgroups by Age
- Catherine R. Rahilly-Tierney, Elizabeth V. Lawler, Richard E. Scranton, and J. Michael Gaziano
Circulation 2009;120:1491-1497; published online before print as doi:10.1161/CIRCULATIONAHA.108.846931
[Abstract]
[Full text]
- Epidemiology and Prevention
Effects of Telmisartan, Ramipril, and Their Combination on Left Ventricular Hypertrophy in Individuals at High Vascular Risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease
- Paolo Verdecchia, Peter Sleight, Giuseppe Mancia, Robert Fagard, Bruno Trimarco, Roland E. Schmieder, Jae-Hyung Kim, Garry Jennings, Petr Jansky, Jyh-Hong Chen, Lisheng Liu, Peggy Gao, Jeffrey Probstfield, Koon Teo, Salim Yusuf for the ONTARGET/TRANSCEND Investigators
Circulation 2009;120:1380-1389; published online before print as doi:10.1161/CIRCULATIONAHA.109.865774
[Abstract]
[Full text]
- Articles
Bleeding Increases the Risk of Ischemic Events in Patients With Peripheral Arterial Disease
- Eline S. van Hattum, Ale Algra, James A. Lawson, Bert C. Eikelboom, Frans L. Moll, and Marco J.D. Tangelder
Circulation published October 5, 2009, doi:10.1161/CIRCULATIONAHA.109.858365
[Abstract]
- Articles
Cardiovascular Benefit of Magnitude of Low-Density Lipoprotein Cholesterol Reduction. A Comparison of Subgroups by Age
- Catherine R. Rahilly-Tierney, Elizabeth V. Lawler, Richard E. Scranton, and J. Michael Gaziano
Circulation published September 28, 2009, doi:10.1161/CIRCULATIONAHA.108.846931
[Abstract]
- Articles
Effects of Telmisartan, Ramipril, and Their Combination on Left Ventricular Hypertrophy in Individuals at High Vascular Risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease
- Paolo Verdecchia, Peter Sleight, Giuseppe Mancia, Robert Fagard, Bruno Trimarco, Roland E. Schmieder, Jae-Hyung Kim, Garry Jennings, Petr Jansky, Jyh-Hong Chen, Lisheng Liu, Peggy Gao, Jeffrey Probstfield, Koon Teo, Salim Yusuf for the ONTARGET/TRANSCEND Investigators
Circulation published September 21, 2009, doi:10.1161/CIRCULATIONAHA.109.865774
[Abstract]
- Editorials
Syncope While Driving: How Safe Is Safe?
- Anne B. Curtis and Andrew E. Epstein
Circulation 2009;120:921-923; published online before print as doi:10.1161/CIRCULATIONAHA.109.890335
[Full text]
- Articles
Syncope While Driving. How Safe Is Safe?
- Anne B. Curtis and Andrew E. Epstein
Circulation published August 31, 2009, doi:10.1161/CIRCULATIONAHA.109.890335
[Abstract]
- Special Report
Is Primary Prevention of Rheumatic Fever the Missing Link in the Control of Rheumatic Heart Disease in Africa?
- Ganesan Karthikeyan and Bongani M. Mayosi
Circulation 2009;120:709-713; published online before print as doi:10.1161/CIRCULATIONAHA.108.836510
[Abstract]
[Full text]
|
|
